Mutagenesis of varicella-zoster virus glycoprotein I (gI) identifies a cysteine residue critical for gE/gI heterodimer formation, gI structure, and virulence in skin cells

Journal of Virology

Volumn 85, Issue 9, 2011, Pages 4095-4110

  Oliver, Stefan L ^a   Sommer, Marvin H ^a   Reichelt, Mike ^a   Rajamani, Jaya ^a   Vlaycheva Beisheim, Leonssia ^a   Stamatis, Shaye ^a   Cheng, Jason ^a   Jones, Carol ^a   Zehnder, James ^a   Arvin, Ann M ^a  

^a STANFORD UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CYSTEINE; HERPES ZOSTER VIRUS GLYCOPROTEIN 1; HETERODIMER; IMMUNOGLOBULIN E; IMMUNOGLOBULIN G1; UNCLASSIFIED DRUG; VIRUS PROTEIN;

ALPHAHERPESVIRINAE; AMINO ACID SUBSTITUTION; ANIMAL CELL; ANIMAL EXPERIMENT; ARTICLE; CONTROLLED STUDY; CYTOPLASM; GENE DUPLICATION; HUMAN; HUMAN CELL; IN VIVO STUDY; MOUSE; MUTAGENESIS; NONHUMAN; OPEN READING FRAME; PATHOGENESIS; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN GLYCOSYLATION; PROTEIN LOCALIZATION; PROTEIN PHOSPHORYLATION; PROTEIN STRUCTURE; SKIN CELL; VARICELLA ZOSTER VIRUS; VIRION; VIRUS GENOME; VIRUS ISOLATION; VIRUS MUTATION; VIRUS PARTICLE; VIRUS PLAQUE; VIRUS REPLICATION; VIRUS VIRULENCE;

AMINO ACID SUBSTITUTION; CELL LINE; CYSTEINE; DNA MUTATIONAL ANALYSIS; HERPESVIRUS 3, HUMAN; HUMANS; PLAQUE ASSAY; PROTEIN INTERACTION MAPPING; PROTEIN MULTIMERIZATION; SEQUENCE DELETION; SKIN; VIRAL ENVELOPE PROTEINS; VIRULENCE; VIRULENCE FACTORS; VIRUS REPLICATION;

ALPHAHERPESVIRINAE; HUMAN HERPESVIRUS 3;

EID: 79955420837     PISSN: 0022538X     EISSN: 10985514     Source Type: Journal    
DOI: 10.1128/JVI.02596-10     Document Type: Article

References (63)

1. Abramoff, M. D., P. J. Magelhaes, and S. J. Ram. 2004. Image processing with ImageJ. Biophotonics Int. 11:36-42.
2. Alconada, A., U. Bauer, and B. Hoflack. 1996. A tyrosine-based motif and a casein kinase II phosphorylation site regulate the intracellular trafficking of the varicella-zoster virus glycoprotein I, a protein localized in the trans-Golgi network. EMBO J. 15:6096-6110.
3. Ali, M. A., Q. Li, E. R. Fischer, and J. I. Cohen. 2009. The insulin degrading enzyme binding domain of varicella-zoster virus (VZV) glycoprotein E is important for cell-to-cell spread and VZV infectivity, while a glycoprotein I binding domain is essential for infection. Virology 386:270-279.
4. Baiker, A., et al. 2004. The immediate-early 63 protein of varicella-zoster virus: analysis of functional domains required for replication in vitro and for T-cell and skin tropism in the SCIDhu model in vivo. J. Virol. 78:1181-1194.
5. Banfield, B. W., G. S. Yap, A. C. Knapp, and L. W. Enquist. 1998. A chicken embryo eye model for the analysis of alphaherpesvirus neuronal spread and virulence. J. Virol. 72:4580-4588.
6. Baucke, R. B., and P. G. Spear. 1979. Membrane proteins specified by herpes simplex viruses. V. Identification of an Fc-binding glycoprotein. J. Virol. 32:779-789.
7. Berarducci, B., et al. 2006. Essential functions of the unique N-terminal region of the varicella-zoster virus glycoprotein E ectodomain in viral replication and in the pathogenesis of skin infection. J. Virol. 80:9481-9496.
8. Berarducci, B., et al. 2009. Deletion of the first cysteine-rich region of the varicella-zoster virus glycoprotein E ectodomain abolishes the gE and gI interaction and differentially affects cell-cell spread and viral entry. J. Virol. 83:228-240.
9. Berarducci, B., et al. 2010. Functions of the unique N-terminal region of glycoprotein E in the pathogenesis of varicella-zoster virus infection. Proc. Natl. Acad. Sci. U. S. A. 107:282-287.
10. Blom, N., S. Gammeltoft, and S. Brunak. 1999. Sequence and structure-based prediction of eukaryotic protein phosphorylation sites. J. Mol. Biol. 294:1351-1362.
11. Bryson, K., et al. 2005. Protein structure prediction servers at University College London. Nucleic Acids Res. 33:W36-W38.
12. Card, J. P., M. E. Whealy, A. K. Robbins, and L. W. Enquist. 1992. Pseu-dorabies virus envelope glycoprotein gI influences both neurotropism and virulence during infection of the rat visual system. J. Virol. 66:3032-3041.
13. Carfi, A., et al. 2001. Herpes simplex virus glycoprotein D bound to the human receptor HveA. Mol. Cell 8:169-179.
14. Chaudhuri, V., M. Sommer, J. Rajamani, L. Zerboni, and A. M. Arvin. 2008. Functions of varicella-zoster virus ORF23 capsid protein in viral replication and the pathogenesis of skin infection. J. Virol. 82:10231-10246.
15. Chowdary, T. K., et al. 2010. Crystal structure of the conserved herpesvirus fusion regulator complex gH-gL. Nat. Struct. Mol. Biol. 17:882-888.
16. Cohen, J. I., S. E. Straus, and A. Arvin. 2007. Varicella-zoster virus replication, pathogenesis and management, p. 3091. In D. M. Knipe, P. M. Howley, D. E. Griffin, R. A. Lamb, M. A. Martin, B. Roizman, and S. E. Straus (ed.), Fields virology, 5th ed. Lippincott Williams & Wilkins, Philadelphia, PA.
17. Davison, A. J., and J. E. Scott. 1986. The complete DNA sequence of varicella-zoster virus. J. Gen. Virol. 67:1759-1816.
18. Dingwell, K. S., et al. 1994. Herpes simplex virus glycoproteins E and I facilitate cell-to-cell spread in vivo and across junctions of cultured cells. J. Virol. 68:834-845.
19. Dingwell, K. S., L. C. Doering, and D. C. Johnson. 1995. Glycoproteins E and I facilitate neuron-to-neuron spread of herpes simplex virus. J. Virol. 69: 7087-7098.
20. Erazo, A., and P. R. Kinchington. 2010. Varicella-zoster virus open reading frame 66 protein kinase and its relationship to alphaherpesvirus US3 kinases. Curr. Top. Microbiol. Immunol. 342:79-98.
21. Farnsworth, A., K. Goldsmith, and D. C. Johnson. 2003. Herpes simplex virus glycoproteins gD and gE/gI serve essential but redundant functions during acquisition of the virion envelope in the cytoplasm. J. Virol. 77:8481-8494.
22. Fuller, A. O., and P. G. Spear. 1987. Anti-glycoprotein D antibodies that permit adsorption but block infection by herpes simplex virus 1 prevent virion-cell fusion at the cell surface. Proc. Natl. Acad. Sci. U. S. A. 84:5454-5458.
23. Grose, C, D. P. Edwards, K. A. Weigle, W. E. Friedrichs, and W. L. McGuire. 1984. Varicella-zoster virus-specific gp140: a highly immunogenic and disulfide-linked structural glycoprotein. Virology 132:138-146.
24. Harlow, E., and D. Lane. 1999. Using antibodies: a laboratory manual. Cold Spring Harbor Laboratory Press, Cold Spring Harbor, NY.
25. Ito, H., et al. 2005. Role of the varicella-zoster virus gene product encoded by open reading frame 35 in viral replication in vitro and in differentiated human skin and T cells in vivo. J. Virol. 79:4819-4827.
26. Kenyon, T. K., and C. Grose. 2010. VZV ORF47 serine protein kinase and its viral substrates. Curr. Top. Microbiol. Immunol. 342:99-111.
27. Kimman, T. G., et al. 1992. Contribution of single genes within the unique short region of Aujeszky's disease virus (suid herpesvirus type 1) to virulence, pathogenesis and immunogenicity. J. Gen. Virol. 73:243-251.
28. Kimura, H., S. E. Straus, and R. K. Williams. 1997. Varicella-zoster virus glycoproteins E and I expressed in insect cells form a heterodimer that requires the N-terminal domain of glycoprotein I. Virology 233:382-391.
29. Li, Q., M. A. Ali, and J. I. Cohen. 2006. Insulin degrading enzyme is a cellular receptor mediating varicella-zoster virus infection and cell-to-cell spread. Cell 127:305-316.
30. Li, Q., T. Krogmann, M. A. Ali, W. J. Tang, and J. I. Cohen. 2007. The amino terminus of varicella-zoster virus (VZV) glycoprotein E is required for binding to insulin-degrading enzyme, a VZV receptor. J. Virol. 81:8525-8532.
31. Ling, P., P. R Kinchington, M. Sadeghi-Zadeh, W. T. Ruyechan, and J. Hay. 1992. Transcription from varicella-zoster virus gene 67 (glycoprotein IV). J. Virol. 66:3690-3698.
32. Litwin, V., W. Jackson, and C. Grose. 1992. Receptor properties of two varicella-zoster virus glycoproteins, gpI and gpIV, homologous to herpes simplex virus gE and gI. J. Virol. 66:3643-3651.
33. Long, D., G. H. Cohen, M. I. Muggeridge, and R J. Eisenberg. 1990. Cysteine mutants of herpes simplex virus type 1 glycoprotein D exhibit temperature-sensitive properties in structure and function. J. Virol. 64:5542-5552.
34. Long, D., W. C. Wilcox, W. R. Abrams, G. H. Cohen, and R J. Eisenberg. 1992. Disulfide bond structure of glycoprotein D of herpes simplex virus types 1 and 2. J. Virol. 66:6668-6685.
35. Lungu, O., C. A. Panagiotidis, P. W. Annunziato, A. A. Gershon, and S. J. Silverstein. 1998. Aberrant intracellular localization of varicella-zoster virus regulatory proteins during latency. Proc. Natl. Acad. Sci. U. S. A. 95:7080-7085.
36. Mallory, S., M. Sommer, and A. M. Arvin. 1997. Mutational analysis of the role of glycoprotein I in varicella-zoster virus replication and its effects on glycoprotein E conformation and trafficking. J. Virol. 71:8279-8288.
37. Maresova, L., T. J. Pasieka, E. Homan, E. Gerday, and C. Grose. 2005. Incorporation of three endocytosed varicella-zoster virus glycoproteins, gE, gH, and gB, into the virion envelope. J. Virol. 79:997-1007.
38. McGeoch, D. J. 1990. Evolutionary relationships of virion glycoprotein genes in the S regions of alphaherpesvirus genomes. J. Gen. Virol. 71:2361-2367.
39. McGeoch, D. J., A. Dolan, and A. C. Ralph. 2000. Toward a comprehensive phylogeny for mammalian and avian herpesviruses. J. Virol. 74:10401-10406.
40. Mijnes, J. D., et al. 1998. The disulfide-bonded structure of feline herpesvirus glycoprotein I. J. Virol. 72:7245-7254.
41. Mo, C, J. Lee, M. Sommer, C. Grose, and A. M. Arvin. 2002. The requirement of varicella zoster virus glycoprotein E (gE) for viral replication and effects of glycoprotein I on gE in melanoma cells. Virology 304:176-186.
42. Moffat, J., H. Ito, M. Sommer, S. Taylor, and A. M. Arvin. 2002. Glycoprotein I of varicella-zoster virus is required for viral replication in skin and T cells. J. Virol. 76:8468-8471.
43. Moffat, J. F., M. D. Stein, H. Kaneshima, and A. M. Arvin. 1995. Tropism of varicella-zoster virus for human CD4+ and CD8+ T lymphocytes and epidermal cells in SCID-hu mice. J. Virol. 69:5236-5242.
44. Nagashunmugam, T., et al. 1998. In vivo immune evasion mediated by the herpes simplex virus type 1 immunoglobulin G Fc receptor. J. Virol. 72: 5351-5359.
45. Oliver, S. L., L. Zerboni, M. Sommer, J. Rajamani, and A. M. Arvin. 2008. Development of recombinant varicella-zoster viruses expressing luciferase fusion proteins for live in vivo imaging in human skin and dorsal root ganglia xenografts. J. Virol. Methods 154:182-193.
46. Olson, J. K., G. A. Bishop, and C. Grose. 1997. Varicella-zoster virus Fc receptor gE glycoprotein: serine/threonine and tyrosine phosphorylation of monomeric and dimeric forms. J. Virol. 71:110-119.
47. Olson, J. K., and C. Grose. 1998. Complex formation facilitates endocytosis of the varicella-zoster virus gE:gI Fc receptor. J. Virol. 72:1542-1551.
48. Pickering, L. K., et al. 2009. Immunization programs for infants, children, adolescents, and adults: clinical practice guidelines by the Infectious Diseases Society of America. Clin. Infect. Dis. 49:817-840.
49. Sprague, E. R., C. Wang, D. Baker, and P. J. Bjorkman. 2006. Crystal structure of the HSV-1 Fc receptor bound to Fc reveals a mechanism for antibody bipolar bridging. PLoS Biol. 4:e148.
50. Tirabassi, R. S., and L. W. Enquist. 2000. Role of the pseudorabies virus gI cytoplasmic domain in neuroinvasion, virulence, and posttranslational N-linked glycosylation. J. Virol. 74:3505-3516.
51. Vafai, A., M. Wellish, Z. Wroblewska, M. Cisco, and D. Gilden. 1987. Induction of antibody against in vitro translation products encoded by varicella-zoster virus glycoprotein genes. Virus Res. 7:325-333.
52. Wang, F., et al. 2005. Herpes simplex virus type 1 glycoprotein e is required for axonal localization of capsid, tegument, and membrane glycoproteins. J. Virol. 79:13362-13372.
53. Wang, Z. H., M. D. Gershon, O. Lungu, Z. Zhu, and A. A. Gershon. 2000. Trafficking of varicella-zoster virus glycoprotein gI: T(338)-dependent retention in the trans-Golgi network, secretion, and mannose 6-phosphate-inhib-itable uptake of the ectodomain. J. Virol. 74:6600-6613.
54. Wang, Z. H., et al. 2001. Essential role played by the C-terminal domain of glycoprotein I in envelopment of varicella-zoster virus in the trans-Golgi network: interactions of glycoproteins with tegument. J. Virol. 75:323-340.
55. Weller, T. H. 1996. Varicella: historical perspective and clinical overview. J. Infect. Dis. 174(Suppl. 3):S306-S309.
56. Yao, Z., and C. Grose. 1994. Unusual phosphorylation sequence in the gpIV (gI) component of the varicella-zoster virus gpI-gpIV glycoprotein complex (VZV gE-gI complex). J. Virol. 68:4204-4211.
57. Yao, Z., W. Jackson, B. Forghani, and C. Grose. 1993. Varicella-zoster virus glycoprotein gpI/gpIV receptor: expression, complex formation, and antigen-icity within the vaccinia virus-T7 RNA polymerase transfection system. J. Virol. 67:305-314.
58. Yao, Z., W. Jackson, and C. Grose. 1993. Identification of the phosphoryla-tion sequence in the cytoplasmic tail of the varicella-zoster virus Fc receptor glycoprotein gpI. J. Virol. 67:4464-4473.
59. Ye, M., K. M. Duus, J. Peng, D. H. Price, and C. Grose. 1999. Varicella-zoster virus Fc receptor component gI is phosphorylated on its endodomain by a cyclin-dependent kinase. J. Virol. 73:1320-1330.
60. Zerboni, L., et al. 2011. Varicella-zoster virus glycoprotein E is a critical determinant of virulence in the SCID mouse-human model of neuropatho-genesis. J. Virol. 85:98-111.
61. Zerboni, L., C. C. Ku, C. D. Jones, J. L. Zehnder, and A. M. Arvin. 2005. Varicella-zoster virus infection of human dorsal root ganglia in vivo. Proc. Natl. Acad. Sci. U. S. A. 102:6490-6495.
62. Zerboni, L., et al. 2007. Aberrant infection and persistence of varicella-zoster virus in human dorsal root ganglia in vivo in the absence of glycoprotein I. Proc. Natl. Acad. Sci. U. S. A. 104:14086-14091.
63. Zuckermann, F. A., T. C. Mettenleiter, C. Schreurs, N. Sugg, and T. Ben-Porat. 1988. Complex between glycoproteins gI and gp63 of pseudorabies virus: its effect on virus replication. J. Virol. 62:4622-4626.